Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00440_DB00784_nanopub.RArSR2SRwUbTNwHLIF01uDdYF5LT4WT4Twh_1Jx7CwTcs#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00440_DB00784 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00440_DB00784 label "DDI between Trimethoprim and Mefenamic acid - The strong CYP2C9 inhibitor, Mefenamic acid, may decrease the metabolism and clearance of Trimethoprim, a CYP2C9 substrate. Consider alternate therapy or monitor for changes in therapeutic and adverse effects of Trimethoprim if Mefenamic acid is initiated, discontinued or dose changed. [drugbank_resource:DB00440_DB00784]" assertion.
- drugbank_resource:DB00440_DB00784 identifier "drugbank_resource:DB00440_DB00784" assertion.
- drugbank_resource:DB00440_DB00784 title "DDI between Trimethoprim and Mefenamic acid - The strong CYP2C9 inhibitor, Mefenamic acid, may decrease the metabolism and clearance of Trimethoprim, a CYP2C9 substrate. Consider alternate therapy or monitor for changes in therapeutic and adverse effects of Trimethoprim if Mefenamic acid is initiated, discontinued or dose changed." assertion.
- drugbank:DB00440 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00440_DB00784 assertion.
- drugbank:DB00784 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00440_DB00784 assertion.